Exercise and Two Different Kinesiotape Applications in Patients With Sacroiliac Joint Dysfunction

April 1, 2021 updated by: Saime Ay, Ufuk University

Exercise and Two Different Kinesiotape Applications in Addition to Exercise in Patients With Sacroiliac Joint Dysfunction: A Randomized Controlled Study

This study is a randomized controlled study. 75 patients between the ages of 20-50 who were diagnosed with sacroiliac joint dysfunction will be included in the study. 25 patients will be given a home exercise program that strengthens the waist and hip girdle (to be shown once in the hospital by a physiotherapist and the form of the exercises will be given), 25 patients will be given kinesiology taping with inhibition technique with the exercise program, and 25 patients will be given kinesiology taping with fascia correction technique with the exercise program. Patients will do the exercises once a day for 1 month. In kinesiology taping with the inhibition method, an I-shaped tape of 15-20 cm in length will be applied on the sacroiliac joint on both sides without stretching the ends with 50% stretching in the middle. In addition, a 25-30 cm long I band will be applied over the right spina iliaca posterior superior, towards the left spina iliaca posterior superior. In the facia correction technique, 2 bands with no cut ends, a 10-15 cm web-shaped band divided into 4 or 5 parts with a width of 1-15 cm will be applied cross over the sacroiliac joint, without stretching the ends with 50% stretching in the middle.

Gillet test (evaluation of sacroiliac joint movement with single hip flexion), Gaenslen test (pain provocation with passive hip flexion), Patrick test (provocation of pain with hip flexion, abduction and external rotation), standing flexion test (evaluation of sacroiliac joint movement with forward flexion), sacroiliac compression and distraction test (provocation of pain with anterior pelvic compression or distraction), long sitting test (pain in the sacroiliac joint after sitting for more than 30 minutes), posterior shear test (provocation of pain with hip flexion and adduction) will be applied to the patients. The patients' resting and moving pain levels will be measured using the Visuel Analog Scale (VAS). Pain duration in the last week will be questioned and noted. Global Assessment of the Patient's Self within the last 1 week will be made over VAS. Oswestry Disability Index (ODI) will be applied to determine the level of disability. Evaluations will be made before, 15 days after and 1 month after treatment.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

75

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Ankara, Turkey
        • Recruiting
        • Ufuk University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

75 patients aged 20-50 years with a diagnosis of sacroiliac joint dysfunction.

Description

Inclusion Criteria:

  • Patients with sacroiliac joint dysfunction between the ages of 20-50
  • Hip and low back pain that does not exceed the 5th lumbar vertebra for at least 3 months
  • Patients with pain radiating 3 cm above and 10 cm below the spina iliaca posterior superior
  • Patients who have not received medical treatment in the last 6 months

Exclusion Criteria:

  • Patients with sacroiliac and inflammatory disease
  • Patients with polyarthrosis, herniated disc, severe symptomatic disc degeneration, spinal stenosis and spondyloarthrosis.
  • Patients with a history of pelvic trauma
  • Patients with metabolic bone disease, infection, malignancy, pregnancy
  • Patients with open wounds in the lumbar and sacral area

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain levels at Visuel Analog Scale
Time Frame: 1 month
The patients' resting and moving pain levels will be measured using the Visuel Analog Scale. Patients will be asked to mark their pain levels on a visual analog scale of 0-10 cm. Higher values indicate more pain.
1 month
Pain duration in the last week
Time Frame: 1 week
Pain duration in the last week
1 week
Global Assessment of the Patient's self at Visuel Analog Scale
Time Frame: 1 week
Global Assessment of the Patient's Self within the last 1 week will be made over Visuel Analog Scale. Patients will be asked to mark their global assessment on a 0-10 cm visual analog scale. Higher values indicate better result.
1 week
Oswestry Disability Index
Time Frame: 1 month
Oswestry Disability Index (ODI) will be applied to determine the level of disability. It is a scale consisting of 10 questions, each scored between 0 and 5 points. The minimum score is 0 and the maximum score is 50. Higher results indicate worse functional status.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: saime ay, Ufuk University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2016

Primary Completion (Anticipated)

December 1, 2022

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

March 29, 2021

First Submitted That Met QC Criteria

April 1, 2021

First Posted (Actual)

April 2, 2021

Study Record Updates

Last Update Posted (Actual)

April 2, 2021

Last Update Submitted That Met QC Criteria

April 1, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 15112016-5

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sacroiliac Joint Somatic Dysfunction

Clinical Trials on kinesio taping

3
Subscribe